comparemela.com

Latest Breaking News On - Prnewswire allgenesis biotherapeutics inc - Page 1 : comparemela.com

Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients

ALHAMBRA, Calif. , June 19, 2023 /PRNewswire/ Allgenesis Biotherapeutics Inc., a clinical-stage specialty pharmaceutical company focused on developing novel ophthalmic drugs, today announced topline data from the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.